Informações:
Falhas:
ID
33559
Descrição
An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01266564
Link
https://clinicaltrials.gov/show/NCT01266564
Palavras-chave
Versões (1)
- 13/12/2018 13/12/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
13 de dezembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Colorectal Cancer NCT01266564
Eligibility Colorectal Cancer NCT01266564
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Cancer NCT01266564
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Adult | Age
Item
adult patients, age >/=18 years
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Secondary malignant neoplasm of large intestine
Item
proven metastatic colorectal carcinoma
boolean
C0346973 (UMLS CUI [1])
Measurable Disease
Item
patients have measurable disease
boolean
C1513041 (UMLS CUI [1])
First line treatment | Avastin
Item
patients are eligible to receive first-line avastin
boolean
C1708063 (UMLS CUI [1])
C1135130 (UMLS CUI [2])
C1135130 (UMLS CUI [2])
Patient data Release Consent
Item
patients have signed data release form
boolean
C2707520 (UMLS CUI [1,1])
C1283071 (UMLS CUI [1,2])
C1511481 (UMLS CUI [1,3])
C1283071 (UMLS CUI [1,2])
C1511481 (UMLS CUI [1,3])
Medical contraindication Avastin
Item
contra-indication to receive avastin according to the local labeling
boolean
C1301624 (UMLS CUI [1,1])
C1135130 (UMLS CUI [1,2])
C1135130 (UMLS CUI [1,2])
Study Subject Participation Status
Item
participation in a clinical study within 30 days prior to enrolment
boolean
C2348568 (UMLS CUI [1])
Primary malignant neoplasm Other
Item
patients have any other primary cancer
boolean
C1306459 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
Biological agents
Item
concomitant treatment with other biologics
boolean
C0005515 (UMLS CUI [1])
Cancer Other | Exception Basal cell carcinoma
Item
history of other malignant disease in the past 5 years except basal cell carcinoma
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])